Choriocarcinoma is an aggressively growing and widely metastasizing tumor that originates from trophoblastic cells. A primary gastric choriocarcinoma (PGC), however, is very rare. A 76-year-old female patient visited the emergency department of Wonkwang University Hospital with abdominal discomfort and melena. Esophagogastroduodenoscopy revealed a huge ulceroinfiltrative mass lesion with blood clots on the boundary between the greater curvature side and the posterior wall side of the stomach lower body. CT showed a 3-cm exophytic mass lesion with heterogeneous enhancement, an ulcer lesion at the posterior wall side of the stomach lower body, and multiple enlarged lymph nodes at the splenic artery and left gastric artery nodal stations. She underwent a radical subtotal gastrectomy with a D2 lymph node dissection. The final diagnosis was PGC coexisting with adenocarcinoma based on the pathology results. This paper reports a rare case of primary gastric choriocarcinoma coexisting with adenocarcinoma and discusses the characteristics of this neoplasm with reference to the literature. (Korean J Gastroenterol 2019;73:350-354) 
INTRODUCTION
Choriocarcinoma is an aggressively growing and widely metastasizing tumor that originates from trophoblastic cells. Most of these tumors occur in the uterus and are related to a normal or abnormal pregnancy. They are often found in extra- Fig. 1 . Esophagogastroduodenoscopy findings. A huge ulceroinfiltrative mass lesion with blood clots on the boundary between the greater curvature side and the posterior wall side of the stomach lower body. Fig. 2 . Abdomen-pelvic computed tomography findings. A 3-cm exophytic mass lesion with heterogeneous enhancement, ulcer lesion at the posterior wall side of the stomach lower body, and multiple enlarged lymph nodes at the splenic artery and left gastric artery nodal stations (white arrow). 10 .50×10 3 /mm 3 ; CRP, 10.86 mg/L; CEA, 7.06 ng/mL; and the other blood chemistry parameters, within normal limits.
Two packs of packed red blood cells were transfused. She also underwent esophagogastroduodenoscopy under the clinical impression of gastrointestinal bleeding. Esophagogastroduodenoscopy revealed a huge ulceroinfiltrative mass lesion with blood clots on the boundary between the greater curvature side and the posterior wall side of the stomach lower body ( Fig. 1 ). CT revealed a 3-cm exophytic mass lesion with heterogeneous enhancement, an ulcer lesion at the posterior wall side of the stomach lower body, and multiple enlarged lymph nodes at the splenic artery and left gastric artery nodal stations ( Fig. 2 ). PET/CT was performed to identify the other primary lesion or metastasis, but there was no abnormality of either ovaries or other organs. No distant metastasis to the other organs was found. The initial endoscopic biopsy result established a diagnosis of a well-differentiated adenocarcinoma. In June 2018, the patient underwent a radical subtotal gastrectomy with a D2 (1, 3, 4sb, 4d, 5, 6, 7, 8a, 9, 11p , and 12a) lymph node dissection and gastroduodenostomy. The surgical findings revealed a 7-cm mass lesion, diagnosed as Borrmann type II advanced gastric cancer in the posterior wall side of the stomach lower body with a 3-cm exophytic mass invading the mesocolon and multiple enlarged lymph nodes at the 6, 7, 8a, and 11p stations.
Pathologically, the tumor had two components. The predominant portion of the tumor, which occupied more than 2/3 of the tumor, consisted of highly pleomorphic, bizarre cells 
DISCUSSION
Choriocarcinoma of the stomach was first described by growth and elimination of a pre-existing adenocarcinoma portion. The retro-differentiation theory is based on the fact that most PGC coexists with gastric adenocarcinoma and that there is a possible transition from an adenocarcinoma to choriocarcinoma. This is supported by the relatively similar clinical features of PGC to gastric adenocarcinoma, such as sex ratio, mean age, and location of the tumor, and about 70% of PGC was reported to be associated with gastric adenocarcinoma. In addition, a previous study on comparative genomic hybridization and fluorescence in situ hybridization reported that PGC genetically has the characteristics of both choriocarcinoma and adenocarcinoma. 1, [16] [17] [18] [19] The clinical manifestations of PGC are also similar to those of gastric adenocarcinoma, accompanied by abdominal pain, weight loss, anorexia, nausea, and vomiting. Gastrointestinal bleeding is more frequent, and some effects of the hormone can lead to gynecomastia, precocious puberty, and vomiting, which are also observed during pregnancy. 19 The present patient, however, had no manifestations of hormone-associated symptoms. PGC is difficult to diagnose in a preoperative endoscopic biopsy because most of the PGCs coexist with adenocarcinoma. Only 8-9.4% of patients are diagnosed correctly before laparotomy. 1, 17 In the present case, the initial diagnosis before surgery was a well-differentiated tubular adenocarcinoma.
The management of choriocarcinoma is not well estab- In conclusion, the authors a case of PGC coexisting with adenocarcinoma that was treated with a radical subtotal gastrectomy with a D2 lymph node dissection. PGC is a very rare disease, but the possibility of this disease must be considered during diagnosis.
